PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF MUCOLIPIDOSIS II, COMPRISING A LYSOSOMAL ENZYME AS AN ACTIVE INGREDIENT

The present invention relates to a pharmaceutical composition for the prevention or treatment of mucolipidosis II, comprising a lysosomal enzyme complex. The composition improves the clinical findings of mucolipidosis II, and thus can be used to advantage in the prevention or treatment of mucolipido...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LEE, SUNG YOUL, PARK, SUNG-ICK
Format:	Patent
Sprache:	eng ; fre ; kor
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a pharmaceutical composition for the prevention or treatment of mucolipidosis II, comprising a lysosomal enzyme complex. The composition improves the clinical findings of mucolipidosis II, and thus can be used to advantage in the prevention or treatment of mucolipidosis II. La présente invention concerne une composition pharmaceutique pour la prévention ou le traitement de la mucolipidose II, comprenant un complexe d'enzyme lysosomale. La composition améliore les découvertes cliniques de la mucolipidose II, et permet ainsi d'être utilisée à profit dans la prévention ou le traitement de la mucolipidose II.